Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Molecular Sciences|February 13, 2026
Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel DiseaseIndiana Zorkau, Peter J Eggenhuizen, Marie Lee, et al.Seminars in Immunopathology|November 24, 2025
The microbiome's hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitisBriana M Peterson, Ina Rudloff, Nadia S Deen, et al.Science Immunology|August 8, 2017
Homodimerization attenuates the anti-inflammatory activity of interleukin-37Andrew M Ellisdon, Claudia A Nold-Petry, Laura D'Andrea, et al.Frontiers in Immunology|July 30, 2019
Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary HypertensionChristine B Bui, Magdalena Kolodziej, Emma Lamanna, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
IL-32 promotes angiogenesisClaudia A Nold-Petry, Ina Rudloff, Yvonne Baumer, et al.Cell Chemical Biology|October 26, 2021
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potentialAlexander Bujotzek, Georg Tiefenthaler, Laurent Lariviere, et al.Nature Immunology|March 3, 2015
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionClaudia A Nold-Petry, Camden Y Lo, Ina Rudloff, et al.Science Translational Medicine|April 6, 2022
Type 2 immune polarization is associated with cardiopulmonary disease in preterm infantsJason C Lao, Christine B Bui, Merrin A Pang, et al.Nature Communications|November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunitiesSteven X Cho, Ina Rudloff, Jason C Lao, et al.Pageof 2